DCF — JOHNSTON HEALTH
Enterprise Value: $267.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$267.3M
Enterprise Value
$70.3M
PV of Cash Flows
$197.0M
PV of Terminal Value
$317.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $341.7M | $34.5M | 10.0% | $13.6M | $12.3M |
| Year 2 | $351.9M | $39.1M | 11.0% | $16.6M | $13.7M |
| Year 3 | $362.5M | $43.9M | 12.0% | $19.8M | $14.9M |
| Year 4 | $373.4M | $47.1M | 13.0% | $21.8M | $14.9M |
| Year 5 | $384.6M | $49.4M | 13.0% | $23.2M | $14.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $267.3M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$331.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.09608312939468983
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5